Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Hanauske

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Oncology (Williston Park, N.Y.)|February 12, 1998
UFT in gastric cancer: current status and future developmentsA R Hanauske
Anti-Cancer Drugs|August 1, 1996
The development of new chemotherapeutic agentsA R Hanauske
Onkologie|December 1, 1990
[Alpha interferon in therapy of non-Hodgkin's lymphoma]M Freund, A R Hanauske
Current Pharmaceutical Design|June 8, 2004
The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsenA-R Hanauske, Karen Sundell, Michael Lahn
FEBS Letters|March 15, 1993
Evidence for binding of extrachromosomal DNA sequences to nuclear matrix proteins in multidrug-resistant KB-V1 cellsF Thiebaut, A R Hanauske, D D Von Hoff
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Effects of the microtubule-disturbing agents docetaxel (Taxotere), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitroA R Hanauske, H Depenbrock, D Shirvani, et al.
The Oncologist|August 29, 2001
Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumorsA R Hanauske, V Chen, P Paoletti, et al.
Investigational New Drugs|January 1, 1995
Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitroH Depenbrock, A Shirvani, J Rastetter, et al.
Investigational New Drugs|January 1, 1995
Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning systemA R Hanauske, G M Clark, D D Von Hoff
Anti-Cancer Drugs|October 1, 1995
Characterization and mutual ligand-induced modulation of epidermal growth factor and interferon-alpha receptors on renal carcinoma cells in vitroH Heise, H Depenbrock, J W Rastetter, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Oncology (Williston Park, N.Y.)|February 12, 1998
UFT in gastric cancer: current status and future developmentsA R Hanauske
Anti-Cancer Drugs|August 1, 1996
The development of new chemotherapeutic agentsA R Hanauske
Onkologie|December 1, 1990
[Alpha interferon in therapy of non-Hodgkin's lymphoma]M Freund, A R Hanauske
Current Pharmaceutical Design|June 8, 2004
The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsenA-R Hanauske, Karen Sundell, Michael Lahn
FEBS Letters|March 15, 1993
Evidence for binding of extrachromosomal DNA sequences to nuclear matrix proteins in multidrug-resistant KB-V1 cellsF Thiebaut, A R Hanauske, D D Von Hoff
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Effects of the microtubule-disturbing agents docetaxel (Taxotere), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitroA R Hanauske, H Depenbrock, D Shirvani, et al.
The Oncologist|August 29, 2001
Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumorsA R Hanauske, V Chen, P Paoletti, et al.
Investigational New Drugs|January 1, 1995
Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitroH Depenbrock, A Shirvani, J Rastetter, et al.
Investigational New Drugs|January 1, 1995
Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning systemA R Hanauske, G M Clark, D D Von Hoff
Anti-Cancer Drugs|October 1, 1995
Characterization and mutual ligand-induced modulation of epidermal growth factor and interferon-alpha receptors on renal carcinoma cells in vitroH Heise, H Depenbrock, J W Rastetter, et al.
Pageof 8